BioReperia
PrivateLast Round
Grant
Apr 13, 2021
Total Funding Raised
$1.7M
Company Overview
BioReperia is a biotechnology company that provides a zebrafish tumor xenograft (ZTX®) platform used to accelerate drug discovery and predict the efficacy of cancer treatments for personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioReperia Comps
Public and private peers based on sector, stage, and business model.
BioReperia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 13, 2021 | ||||
| Series A | Jul 1, 2019 |
Key People
Founding team and executive leadership
BioReperia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LiU Invest | Seed |
| Almi Invest AB | Series A |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 37% MoM.
- Jun 1, 2025
Monthly visitors grew 212% MoM, from 417 to 1.3K.
BioReperia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioReperia's valuation, stock price, and market status.
